ReviewFrontiers in pharmacology2022

Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19.

Rajashri R Naik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.